CMS proposes changes to MA, prescription drug programs
The Centers for Medicare & Medicaid Services late this afternoon released a proposed rule that would make programmatic and operational changes to the Medicare Advantage and prescription drug benefit programs for contract year 2019. According to the agency, the rule would revise program regulations to implement certain provisions of the Comprehensive Addiction and Recovery Act and the 21st Century Cures Act, among other changes. AHA staff are reviewing the rule. Watch for more information.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services Feb. 2 updated guidance originally issued in September on a budget reconciliation bill …
Headline
A KFF survey published today found that people view prior authorization as the biggest challenge beyond costs when navigating the health care system. In terms…
Headline
The Centers for Medicare & Medicaid Services Jan. 29 issued a final rule regarding states non-uniform or non-broad-based provider tax, as authorized under…
Headline
The Department of Health and Human Services Office of Inspector General Jan. 27 released a bulletin addressing how direct-to-consumer drug programs can sell…
Headline
The Centers for Medicare & Medicaid Services Jan. 27 announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations.…
Headline
A KFF analysis released Jan. 28 found that Medicare Advantage insurers made nearly 53 million prior authorization determinations in 2024, an increase…